Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomized, placebo-controlled trial: CRASH-3 trial collaborators. The Lancet. 2019. doi: 10.1016/S0140-6736(1932233-0). [Epub ahead of print]